Global Viscosupplementation Injection 麻豆原创 Research Report 2024

Publication ID:

PB509240315

Publication Date:

September 24, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis. Viscosupplementation can significantly reduce pain while improving the mobility and function of the joint to make activities of daily living and even athletic or strenuous exercise less painful. Viscosupplementation is a procedure that involves injecting hyaluronic acid, a gel-like fluid, directly into the joint. Hyaluronic acid is found naturally in the synovial fluid surrounding the joints to reduce friction during movement. The injection goes into effect by lubricating the joint and assisting the synovial fluid to create more cushion. This works to reduce pain and improve the range of motion or the mobility of the joint.
The global Viscosupplementation Injection market was valued at US$ 1211 million in 2023 and is anticipated to reach US$ 1775 million by 2030, witnessing a CAGR of 5.7% during the forecast period 2024-2030.
The viscosupplementation injection market is driven by the rising prevalence of osteoarthritis, particularly among the aging population. As this treatment involves injecting hyaluronic acid into the joints to improve mobility and reduce pain, it offers a non-surgical alternative to managing osteoarthritis symptoms. The growing demand for minimally invasive procedures and the increasing awareness of joint health are also propelling the market forward. Additionally, advancements in injection technology and the development of next-generation viscosupplements are enhancing treatment outcomes, further supporting market growth.
However, the market faces challenges, including the high cost of viscosupplementation procedures, which can limit patient access, especially in developing regions. Moreover, the treatment's effectiveness may vary between patients, with some experiencing limited relief, which can reduce overall patient satisfaction. Competition from alternative treatments, such as corticosteroid injections and joint replacement surgeries, also presents a challenge to the market's expansion. Regulatory hurdles and reimbursement issues may further impact market growth, as insurers may not fully cover these treatments.
North America is the largest consumption place, with a consumption market share nearly 51% in 2023. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 26%. 麻豆原创 competition is intense. Sanofi, Bioventus, Seikagaku, Anika Therapeutics, LG Chem, Ferring, etc. are the leaders of the industry. Top six company with about 43% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Viscosupplementation Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viscosupplementation Injection.
The Viscosupplementation Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Viscosupplementation Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viscosupplementation Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng
Segment by Type
Single Injection
Three Injection
Five Injection
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Viscosupplementation Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Viscosupplementation Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Viscosupplementation Injection 麻豆原创 Overview
1.1 Product Definition
1.2 Viscosupplementation Injection by Type
1.2.1 Global Viscosupplementation Injection 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Single Injection
1.2.3 Three Injection
1.2.4 Five Injection
1.3 Viscosupplementation Injection by Application
1.3.1 Global Viscosupplementation Injection 麻豆原创 Value by Application (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Viscosupplementation Injection 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Viscosupplementation Injection Revenue 2019-2030
1.4.2 Global Viscosupplementation Injection Sales 2019-2030
1.4.3 Global Viscosupplementation Injection 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Viscosupplementation Injection 麻豆原创 Competition by Manufacturers
2.1 Global Viscosupplementation Injection Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Viscosupplementation Injection Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Viscosupplementation Injection Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Viscosupplementation Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Viscosupplementation Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Viscosupplementation Injection, Product Type & Application
2.7 Global Key Manufacturers of Viscosupplementation Injection, Date of Enter into This Industry
2.8 Global Viscosupplementation Injection 麻豆原创 Competitive Situation and Trends
2.8.1 Global Viscosupplementation Injection 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Viscosupplementation Injection Players 麻豆原创 Share by Revenue
2.8.3 Global Viscosupplementation Injection 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Viscosupplementation Injection 麻豆原创 Scenario by Region
3.1 Global Viscosupplementation Injection 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Viscosupplementation Injection Sales by Region: 2019-2030
3.2.1 Global Viscosupplementation Injection Sales by Region: 2019-2024
3.2.2 Global Viscosupplementation Injection Sales by Region: 2025-2030
3.3 Global Viscosupplementation Injection Revenue by Region: 2019-2030
3.3.1 Global Viscosupplementation Injection Revenue by Region: 2019-2024
3.3.2 Global Viscosupplementation Injection Revenue by Region: 2025-2030
3.4 North America Viscosupplementation Injection 麻豆原创 Facts & Figures by Country
3.4.1 North America Viscosupplementation Injection 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Viscosupplementation Injection Sales by Country (2019-2030)
3.4.3 North America Viscosupplementation Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Viscosupplementation Injection 麻豆原创 Facts & Figures by Country
3.5.1 Europe Viscosupplementation Injection 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Viscosupplementation Injection Sales by Country (2019-2030)
3.5.3 Europe Viscosupplementation Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Viscosupplementation Injection 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Viscosupplementation Injection 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Viscosupplementation Injection Sales by Region (2019-2030)
3.6.3 Asia Pacific Viscosupplementation Injection Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Viscosupplementation Injection 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Viscosupplementation Injection 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Viscosupplementation Injection Sales by Country (2019-2030)
3.7.3 Latin America Viscosupplementation Injection Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Viscosupplementation Injection 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Viscosupplementation Injection 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Viscosupplementation Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Viscosupplementation Injection Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Viscosupplementation Injection Sales by Type (2019-2030)
4.1.1 Global Viscosupplementation Injection Sales by Type (2019-2024)
4.1.2 Global Viscosupplementation Injection Sales by Type (2025-2030)
4.1.3 Global Viscosupplementation Injection Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Viscosupplementation Injection Revenue by Type (2019-2030)
4.2.1 Global Viscosupplementation Injection Revenue by Type (2019-2024)
4.2.2 Global Viscosupplementation Injection Revenue by Type (2025-2030)
4.2.3 Global Viscosupplementation Injection Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Viscosupplementation Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Viscosupplementation Injection Sales by Application (2019-2030)
5.1.1 Global Viscosupplementation Injection Sales by Application (2019-2024)
5.1.2 Global Viscosupplementation Injection Sales by Application (2025-2030)
5.1.3 Global Viscosupplementation Injection Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Viscosupplementation Injection Revenue by Application (2019-2030)
5.2.1 Global Viscosupplementation Injection Revenue by Application (2019-2024)
5.2.2 Global Viscosupplementation Injection Revenue by Application (2025-2030)
5.2.3 Global Viscosupplementation Injection Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Viscosupplementation Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Viscosupplementation Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Viscosupplementation Injection Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Anika Therapeutics
6.2.1 Anika Therapeutics Company Information
6.2.2 Anika Therapeutics Description and Business Overview
6.2.3 Anika Therapeutics Viscosupplementation Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Anika Therapeutics Viscosupplementation Injection Product Portfolio
6.2.5 Anika Therapeutics Recent Developments/Updates
6.3 Seikagaku
6.3.1 Seikagaku Company Information
6.3.2 Seikagaku Description and Business Overview
6.3.3 Seikagaku Viscosupplementation Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Seikagaku Viscosupplementation Injection Product Portfolio
6.3.5 Seikagaku Recent Developments/Updates
6.4 Zimmer Biomet
6.4.1 Zimmer Biomet Company Information
6.4.2 Zimmer Biomet Description and Business Overview
6.4.3 Zimmer Biomet Viscosupplementation Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zimmer Biomet Viscosupplementation Injection Product Portfolio
6.4.5 Zimmer Biomet Recent Developments/Updates
6.5 Bioventus
6.5.1 Bioventus Company Information
6.5.2 Bioventus Description and Business Overview
6.5.3 Bioventus Viscosupplementation Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bioventus Viscosupplementation Injection Product Portfolio
6.5.5 Bioventus Recent Developments/Updates
6.6 Ferring
6.6.1 Ferring Company Information
6.6.2 Ferring Description and Business Overview
6.6.3 Ferring Viscosupplementation Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ferring Viscosupplementation Injection Product Portfolio
6.6.5 Ferring Recent Developments/Updates
6.7 LG Chem
6.7.1 LG Chem Company Information
6.7.2 LG Chem Description and Business Overview
6.7.3 LG Chem Viscosupplementation Injection Sales, Revenue and Gross Margin (2019-2024)
6.7.4 LG Chem Viscosupplementation Injection Product Portfolio
6.7.5 LG Chem Recent Developments/Updates
6.8 Freda
6.8.1 Freda Company Information
6.8.2 Freda Description and Business Overview
6.8.3 Freda Viscosupplementation Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Freda Viscosupplementation Injection Product Portfolio
6.8.5 Freda Recent Developments/Updates
6.9 Haohai Biological
6.9.1 Haohai Biological Company Information
6.9.2 Haohai Biological Description and Business Overview
6.9.3 Haohai Biological Viscosupplementation Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Haohai Biological Viscosupplementation Injection Product Portfolio
6.9.5 Haohai Biological Recent Developments/Updates
6.10 Shanghai Jingfeng
6.10.1 Shanghai Jingfeng Company Information
6.10.2 Shanghai Jingfeng Description and Business Overview
6.10.3 Shanghai Jingfeng Viscosupplementation Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Shanghai Jingfeng Viscosupplementation Injection Product Portfolio
6.10.5 Shanghai Jingfeng Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Viscosupplementation Injection Industry Chain Analysis
7.2 Viscosupplementation Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Viscosupplementation Injection Production Mode & Process
7.4 Viscosupplementation Injection Sales and 麻豆原创ing
7.4.1 Viscosupplementation Injection Sales Channels
7.4.2 Viscosupplementation Injection Distributors
7.5 Viscosupplementation Injection Customers
8 Viscosupplementation Injection 麻豆原创 Dynamics
8.1 Viscosupplementation Injection Industry Trends
8.2 Viscosupplementation Injection 麻豆原创 Drivers
8.3 Viscosupplementation Injection 麻豆原创 Challenges
8.4 Viscosupplementation Injection 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.